Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-11-028142
Filing Date
2011-03-23
Accepted
2011-03-23 13:20:33
Documents
13
Period of Report
2011-05-04
Effectiveness Date
2011-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A c14284def14a.htm DEF 14A 504562
2 GRAPHIC c14284c1428400.gif GRAPHIC 3636
3 GRAPHIC c14284c1428401.gif GRAPHIC 3208
4 GRAPHIC c14284c1428402.gif GRAPHIC 1782
5 GRAPHIC c14284c1428403.jpg GRAPHIC 7514
6 GRAPHIC c14284c1428404.jpg GRAPHIC 9182
7 GRAPHIC c14284c1428405.jpg GRAPHIC 7620
8 GRAPHIC c14284c1428406.jpg GRAPHIC 9130
9 GRAPHIC c14284c1428407.jpg GRAPHIC 7234
10 GRAPHIC c14284c1428408.jpg GRAPHIC 7634
11 GRAPHIC c14284c1428409.jpg GRAPHIC 8503
12 GRAPHIC c14284c1428410.jpg GRAPHIC 7672
13 GRAPHIC c14284c1428411.jpg GRAPHIC 29416
  Complete submission text file 0000950123-11-028142.txt   648767
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19271 | Film No.: 11705992
SIC: 2835 In Vitro & In Vivo Diagnostic Substances